Proxy Statement Form 8 K

Item 5.08 Shareholder Director Nominations

On November 22, 2024, MEI Pharma, Inc. (the "Company") announced that the Company's 2025 Annual Meeting of Stockholders (the "2025 Annual Meeting") will be held on January 30, 2025. The Company's stockholders of record as of the close of business on December 9, 2024 shall be entitled to notice of and to vote at the 2025 Annual Meeting. The Company has set a deadline, as set forth in the following paragraph, for the receipt of stockholder proposals submitted pursuant to Rule 14a-8 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), for inclusion in the Company's proxy materials for the 2025 Annual Meeting. Pursuant to the rules of the Securities and Exchange Commission ("SEC"), the Company is providing notice of the deadlines for such proposals by means of this Current Report on Form 8-K.

Any stockholder proposal intended to be considered for inclusion in the Company's proxy materials for the 2025 Annual Meeting in accordance with Rule 14a-8 must be delivered to, or mailed and received at, the Company's principal executive offices at 9920 Pacific Heights Blvd., Suite 150, San Diego, California 92121 on or before the close of business on [December 10, 2024], which is the [51st] day prior to January 30, 2025 and which the Company has determined to be a reasonable time before it expects to begin to print and distribute its proxy materials prior to the 2025 Annual Meeting. In addition to complying with this deadline, stockholder proposals intended to be considered for inclusion in the Company's proxy materials for the 2025 Annual Meeting must also comply with all applicable SEC rules.

There is a separate submission period applicable to the submission by stockholders of notice of a director nomination or a stockholder proposal outside of the processes of Rule 14a-8. Under the Company's Sixth Amended and Restated Bylaws, such a nomination or proposal must be received by the Secretary of the Company not later than the 90th day, nor earlier than the 120th day, prior to the first anniversary of the preceding year's annual meeting, so long as the current year's meeting is not greater than 30 days before or greater than 60 days after the anniversary date of the preceding year's meeting. The Company's 2024 Annual Meeting of Stockholders was held on December 18, 2024. The 2025 Annual Meeting is to be held fewer than 60 days following the first anniversary of such meeting. Therefore, the deadline for receipt of notice of such a nomination or proposal previously disclosed by the Company, September 18, 2024, remains applicable. Accordingly, such deadline by which notice must have been received at the Company's executive offices to be considered timely has passed.